Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Ready to commit to studying? Coach Beverly recommends our Live Seminar in San Diego or our 1 year subscription for those studying for the BC-ADM. Our Live seminar is a … Continue reading Free Resource Friday | Preparing for the BC-ADM Exam Webinar
In a randomized phase 3a study published in Diabetes Care, those taking oral semaglutide monotherapy experienced superior and clinically significant improvements in A1c and weight loss compared to those taking … Continue reading Oral GLP-1 RA lowers Weight and A1c
August Newsletter Now Available! In our August Newsletter, we highlight several exciting new releases! Nasal Glucagon has been approved, generic Dapagliflozin has been released, and Cleveland Clinic has synthesized a … Continue reading August Newsletter | Diabetes Medications Approved & Supplements Reviewed
The marketing application for a generic version of Farxiga, or dapagliflozin has received tentative approval from the US Food and Drug Administration (USFDA). Alembic Pharmaceuticals received a nod for its … Continue reading Dapagliflozin biosimilar gets tentative FDA approval
New studies show that sitting for too long can impair health and even shorten life expectancy. It’s difficult to keep active in a world of screens, movie theaters, and desk … Continue reading 5 Steps to Stop Sitting and Increase Longevity
Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday … Continue reading Question of the Week | August 6, 2019
While most know there are great benefits to getting out in nature, Medical News Today has released a study showing that simply viewing nature can reduce cravings such as smoking, … Continue reading Getting Back to Basics: How Green is Good
Based on a study published in Diabetes Care in April 2019, it appears that there is a positive association between use of topical corticosteroids and new incident diabetes. A Danish … Continue reading Do topical steroids increase risk of type 2 diabetes?